Back
Microsoft Corp. Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Sell
40
MSFT
Microsoft Corp.
Last Price:
$478.37
Seasonality Move:
5.2%
Buy
64
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$571.29
Seasonality Move:
13.5%
Sell
40
Microsoft Corp. (MSFT)
is a Sell
Is Microsoft Corp. a Buy, Sell or Hold?
-
The current Microsoft Corp. [MSFT] share price is $478.53. The Score for MSFT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
MSFT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $571.44. The Score for MDGL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MSFT Stock Price Chart
What is Microsoft Corp.'s stock price today?
-
The Microsoft Corp. share price today is $478.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSFT is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $571.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight buying pressure.
MSFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.18 | Sell |
| Relative Strength Index (14 RSI): | 41.49 | Sell |
| Chaikin Money Flow: | -6016238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (477.97 - 501.69) | Sell |
| Bollinger Bands (100): | (493.74 - 523.76) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20 | Buy |
| Relative Strength Index (14 RSI): | 59.62 | Buy |
| Chaikin Money Flow: | 50743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (528.97 - 586.99) | Buy |
| Bollinger Bands (100): | (367.46 - 524.18) | Buy |
MSFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 483.17 | Sell |
| 20-day SMA: | 485.99 | Sell |
| 50-day SMA: | 504.67 | Sell |
| 200-day SMA: | 471.9 | Buy |
| 8-day EMA: | 483.37 | Sell |
| 20-day EMA: | 488.22 | Sell |
| 50-day EMA: | 497.69 | Sell |
| 200-day EMA: | 480.75 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 570.14 | Buy |
| 20-day SMA: | 568.95 | Buy |
| 50-day SMA: | 496.62 | Buy |
| 200-day SMA: | 377.22 | Buy |
| 8-day EMA: | 568.69 | Buy |
| 20-day EMA: | 556.87 | Buy |
| 50-day EMA: | 511.83 | Buy |
| 200-day EMA: | 403.9 | Buy |
Microsoft Corp. Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and an increase next year of $2.81 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.27 per share, and an increase next year of $13.90 per share.
Microsoft Corp. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||